Ninety-three percent of Ontario plans now sit fully funded on a solvency basis
SpaceX now swings between 4 and 9% of the portfolio, forcing new risk parameters
Health Canada keeps reviewing daraxonrasib as its US price hits US$39,800 monthly
Adults aged 45 to 54 report the sharpest drop in happiness of any age group
Canadian plans take the opposite turn as generic Ozempic lands at 35% of list price
